In AD, several astrocytic functions are compromised, including glutamine metabolism [173], connexin 43 hemichannels [174], insulin-like growth factor receptor 1 [175], CB1 receptor signaling [123], D-serine production [59], mitochondrial ROS regulation [176], and p75 neurotrophin receptor function [177]. This evidence concerns the gene GJA1 and Alzheimer disease.